Anthony P. FORD

Person

Palo Alto, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Methods for improving neurological diseases and disorders
- Patent number 11,607,395
- Issue date Mar 21, 2023
- Curasen Therapeutics, Inc.
- Anthony P. Ford
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted pyrazole-pyrimidines, variants thereof, and uses therefore
- Patent number 11,591,315
- Issue date Feb 28, 2023
- Merck Sharp & Dohme LLC
- Ronald Charles Hawley
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods for treating neurological disorders with α1A-AR partial ago...
- Patent number 11,590,107
- Issue date Feb 28, 2023
- CuraSen Therapeutics, Inc.
- Anthony P. Ford
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Diaminopyrimidine P2X3 and P2X2/3 receptor modulators for use in th...
- Patent number 11,260,056
- Issue date Mar 1, 2022
- Afferent Pharmaceuticals, Inc.
- Anthony P. Ford
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrimidines and variants thereof, and uses therefor
- Patent number 11,230,532
- Issue date Jan 25, 2022
- Afferent Pharmaceuticals, Inc.
- Ronald Charles Hawley
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline salts and polymorphs of a P2X3 antagonist
- Patent number 11,230,533
- Issue date Jan 25, 2022
- Afferent Pharmaceuticals, Inc.
- Prabha Ibrahim
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Beta adrenergic agonist and methods of using the same
- Patent number 11,040,944
- Issue date Jun 22, 2021
- CuraSen Therapeutics, Inc.
- Anthony P. Ford
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted pyrazole-pyrimidines, variants thereof, and uses therefore
- Patent number 10,988,460
- Issue date Apr 27, 2021
- Afferent Pharmaceuticals, Inc.
- Ronald Charles Hawley
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Beta adrenergic agonist and methods of using the same
- Patent number 10,947,196
- Issue date Mar 16, 2021
- CuraSen Therapeutics, Inc.
- Anthony P. Ford
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrimidines and variants thereof, and uses therefor
- Patent number 10,822,311
- Issue date Nov 3, 2020
- Afferent Pharmaceuticals, Inc.
- Ronald Charles Hawley
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline salts and polymorphs of a P2X3 antagonist
- Patent number 10,676,444
- Issue date Jun 9, 2020
- Afferent Pharmaceuticals, Inc.
- Prabha Ibrahim
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrimidines and variants thereof, and uses therefor
- Patent number 10,662,162
- Issue date May 26, 2020
- Afferent Pharmaceuticals, Inc.
- Ronald Charles Hawley
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods and compositions for treating diseases and conditions
- Patent number 10,543,211
- Issue date Jan 28, 2020
- Afferent Pharmaceuticals, Inc.
- Anthony P. Ford
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted pyrimidines for treatment of chronic cough, neuronal hy...
- Patent number 10,206,922
- Issue date Feb 19, 2019
- Afferent Pharmaceuticals, Inc.
- Anthony P. Ford
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for treating diseases and conditions
- Patent number 10,195,198
- Issue date Feb 5, 2019
- Afferent Pharmaceuticals, Inc.
- Anthony P. Ford
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted pyrimidines for treatment of a cough selected from chro...
- Patent number 9,724,346
- Issue date Aug 8, 2017
- Afferent Pharmaceuticals Inc.
- Anthony P. Ford
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted pyrimidines for treatment of acute cough, chronic cough...
- Patent number 9,284,279
- Issue date Mar 15, 2016
- Afferent Pharmaceuticals, Inc.
- Anthony P. Ford
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of using diaminopyrimidine as P2X3 and P2X⅔ receptor modula...
- Patent number 8,524,725
- Issue date Sep 3, 2013
- Roćhe Palo Alto LLC
- Chris Allen Broka
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of using diaminopyrimidine P2X3 and P2X2/3 receptor modulat...
- Patent number 8,008,313
- Issue date Aug 30, 2011
- Roćhe Palo Alto LLC
- Chris Allen Broka
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Imidazole derivatives
- Patent number 7,531,529
- Issue date May 12, 2009
- Roćhe Palo Alto LLC
- Bernd Buettelmann
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method for screening compounds for alpha1B adrenergic receptor anta...
- Patent number 6,733,982
- Issue date May 11, 2004
- Syntex (USA) LLC
- Anthony P. D. W. Ford
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of purinergic receptor modulators and related reagents
- Patent number 6,515,198
- Issue date Feb 4, 2003
- Syntex (USA) LLC
- Debra Ann Cockayne
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Oxazolone derivatives and uses thereof
- Patent number 6,355,641
- Issue date Mar 12, 2002
- Syntex (USA) LLC
- David Llewellyn Coffen
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME
- Publication number 20240352002
- Publication date Oct 24, 2024
- CuraSen Therapeutics, Inc.
- Jiaxin Yu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DIAMINOPYRIMIDINE P2X3 AND P2X2/3 RECEPTOR MODULATORS FOR USE IN TH...
- Publication number 20240285620
- Publication date Aug 29, 2024
- Afferent Pharmaceuticals, Inc.
- Anthony P. Ford
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME
- Publication number 20240270701
- Publication date Aug 15, 2024
- CuraSen Therapeutics, Inc.
- Jiaxin Yu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TREATING PATIENTS WITH AMYOTROPHIC LAT...
- Publication number 20230414588
- Publication date Dec 28, 2023
- CuraSen Therapeutics, Inc.
- Anthony P. Ford
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ALPHA1A-ADRENERGIC RECEPTOR AGONISTS AND METHODS OF USE
- Publication number 20230312524
- Publication date Oct 5, 2023
- CuraSen Therapeutics, Inc.
- David Scott Carter
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS FOR IMPROVING NEUROLOGICAL DISEASES AND DI...
- Publication number 20230263749
- Publication date Aug 24, 2023
- CuraSen Therapeutics, Inc.
- Anthony P. Ford
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR IMPROVING NEUROLOGICAL DISEASES AND DISORDERS
- Publication number 20230181492
- Publication date Jun 15, 2023
- CuraSen Therapeutics, Inc.
- Anthony P. Ford
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR IMPROVING NEUROLOGICAL DISEASES AND DI...
- Publication number 20230157974
- Publication date May 25, 2023
- CuraSen Therapeutics, Inc.
- Anthony P. Ford
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR TREATING NEUROLOGICAL DISORDERS WITH ALPHA1A-AR PARTIAL...
- Publication number 20220401415
- Publication date Dec 22, 2022
- CuraSen Therapeutics, Inc.
- Anthony P. Ford
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME
- Publication number 20220315534
- Publication date Oct 6, 2022
- CuraSen Therapeutics, Inc.
- Anthony P. Ford
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME
- Publication number 20220169612
- Publication date Jun 2, 2022
- CuraSen Therapeutics, Inc.
- Anthony P. Ford
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DIAMINOPYRIMIDINE P2X3 AND P2X2/3 RECEPTOR MODULATORS FOR USE IN TH...
- Publication number 20220143015
- Publication date May 12, 2022
- Afferent Pharmaceuticals, Inc.
- Anthony P. Ford
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME
- Publication number 20210371380
- Publication date Dec 2, 2021
- CuraSen Therapeutics, Inc.
- Anthony P. Ford
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR IMPROVING NEUROLOGICAL DISEASES AND DISORDERS
- Publication number 20210251923
- Publication date Aug 19, 2021
- CuraSen Therapeutics, Inc.
- Anthony P. Ford
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR DIAGNOSING, MONITORING AND TREATING NEUROLOGICAL DISEAS...
- Publication number 20210251559
- Publication date Aug 19, 2021
- CuraSen Therapeutics, Inc.
- Anthony P. Ford
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR IMPROVING NEUROLOGICAL DISEASES AND DISORDERS
- Publication number 20210186897
- Publication date Jun 24, 2021
- CuraSen Therapeutics, Inc.
- Anthony P. Ford
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED PYRAZOLE-PYRIMIDINES, VARIANTS THEREOF, AND USES THEREFORE
- Publication number 20210171505
- Publication date Jun 10, 2021
- Afferent Pharmaceuticals, Inc.
- Ronald Charles Hawley
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS FOR TREATING NEUROLOGICAL DISORDERS WITH a1A-AR PARTIAL AGO...
- Publication number 20210121445
- Publication date Apr 29, 2021
- CuraSen Therapeutics, Inc.
- Anthony P. Ford
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR TREATING NEUROLOGICAL DISORDERS WITH a1A-AR PARTIAL AGO...
- Publication number 20210121444
- Publication date Apr 29, 2021
- CURASEN THERAPEUTICS, INC.
- Anthony P. Ford
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF USING DIAMINOPYRIMIDINE P2X3 AND P2X2/3 RECEPTOR MODULAT...
- Publication number 20210008071
- Publication date Jan 14, 2021
- Roche Palo Alto LLC
- Chris Allen Broka
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME
- Publication number 20200308114
- Publication date Oct 1, 2020
- CURASEN THERAPEUTICS, INC.
- Anthony P. Ford
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME
- Publication number 20200308115
- Publication date Oct 1, 2020
- Anthony P. Ford
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTALLINE SALTS AND POLYMORPHS OF A P2X3 ANTAGONIST
- Publication number 20200255386
- Publication date Aug 13, 2020
- Afferent Pharmaceuticals, Inc.
- Prabha Ibrahim
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRIMIDINES AND VARIANTS THEREOF, AND USES THEREFOR
- Publication number 20200239421
- Publication date Jul 30, 2020
- Afferent Pharmaceuticals Inc.
- Ronald Charles Hawley
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED PYRAZOLE-PYRIMIDINES, VARIANTS THEREOF, AND USES THEREFORE
- Publication number 20200239451
- Publication date Jul 30, 2020
- Afferent Pharmaceuticals, Inc.
- Ronald Charles Hawley
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS AND COMPOSITIONS FOR TREATING DISEASES AND CONDITIONS
- Publication number 20200108065
- Publication date Apr 9, 2020
- Afferent Pharmaceuticals, Inc.
- Anthony P. Ford
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRIMIDINES AND VARIANTS THEREOF, AND USES THEREFOR
- Publication number 20190389811
- Publication date Dec 26, 2019
- Afferent Pharmaceuticals Inc.
- Ronald Charles Hawley
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE SALTS AND POLYMORPHS OF A P2X3 ANTAGONIST
- Publication number 20190315698
- Publication date Oct 17, 2019
- Afferent Pharmaceuticals, Inc.
- Prabha Ibrahim
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR TREATING DISEASES AND CONDITIONS
- Publication number 20190175593
- Publication date Jun 13, 2019
- Afferent Pharmaceuticals, Inc.
- Anthony P. Ford
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRIMIDINES AND VARIANTS THEREOF, AND USES THEREFOR
- Publication number 20190055202
- Publication date Feb 21, 2019
- Afferent Pharmaceuticals Inc.
- Ronald Charles Hawley
- C07 - ORGANIC CHEMISTRY

Anthony P. FORD

Person

Patents Grantslast 30 patents

Methods for improving neurological diseases and disorders

Substituted pyrazole-pyrimidines, variants thereof, and uses therefore

Methods for treating neurological disorders with α1A-AR partial ago...

Diaminopyrimidine P2X3 and P2X2/3 receptor modulators for use in th...

Pyrimidines and variants thereof, and uses therefor

Crystalline salts and polymorphs of a P2X3 antagonist

Beta adrenergic agonist and methods of using the same

Substituted pyrazole-pyrimidines, variants thereof, and uses therefore

Beta adrenergic agonist and methods of using the same

Pyrimidines and variants thereof, and uses therefor

Crystalline salts and polymorphs of a P2X3 antagonist

Pyrimidines and variants thereof, and uses therefor

Methods and compositions for treating diseases and conditions

Substituted pyrimidines for treatment of chronic cough, neuronal hy...

Methods and compositions for treating diseases and conditions

Substituted pyrimidines for treatment of a cough selected from chro...

Substituted pyrimidines for treatment of acute cough, chronic cough...

Methods of using diaminopyrimidine as P2X3 and P2X⅔ receptor modula...

Methods of using diaminopyrimidine P2X3 and P2X2/3 receptor modulat...

Imidazole derivatives

Method for screening compounds for alpha1B adrenergic receptor anta...

Use of purinergic receptor modulators and related reagents

Oxazolone derivatives and uses thereof

Patents Applicationslast 30 patents

BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME

DIAMINOPYRIMIDINE P2X3 AND P2X2/3 RECEPTOR MODULATORS FOR USE IN TH...

BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME

COMPOSITIONS AND METHODS FOR TREATING PATIENTS WITH AMYOTROPHIC LAT...

ALPHA1A-ADRENERGIC RECEPTOR AGONISTS AND METHODS OF USE

COMPOSITIONS AND METHODS FOR IMPROVING NEUROLOGICAL DISEASES AND DI...

METHODS FOR IMPROVING NEUROLOGICAL DISEASES AND DISORDERS

COMPOSITIONS AND METHODS FOR IMPROVING NEUROLOGICAL DISEASES AND DI...

METHODS FOR TREATING NEUROLOGICAL DISORDERS WITH ALPHA1A-AR PARTIAL...

BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME

BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME

DIAMINOPYRIMIDINE P2X3 AND P2X2/3 RECEPTOR MODULATORS FOR USE IN TH...

BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME

METHODS FOR IMPROVING NEUROLOGICAL DISEASES AND DISORDERS

METHODS FOR DIAGNOSING, MONITORING AND TREATING NEUROLOGICAL DISEAS...

METHODS FOR IMPROVING NEUROLOGICAL DISEASES AND DISORDERS

SUBSTITUTED PYRAZOLE-PYRIMIDINES, VARIANTS THEREOF, AND USES THEREFORE

METHODS FOR TREATING NEUROLOGICAL DISORDERS WITH a1A-AR PARTIAL AGO...

METHODS FOR TREATING NEUROLOGICAL DISORDERS WITH a1A-AR PARTIAL AGO...

METHODS OF USING DIAMINOPYRIMIDINE P2X3 AND P2X2/3 RECEPTOR MODULAT...

BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME

BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME

CRYSTALLINE SALTS AND POLYMORPHS OF A P2X3 ANTAGONIST

PYRIMIDINES AND VARIANTS THEREOF, AND USES THEREFOR

SUBSTITUTED PYRAZOLE-PYRIMIDINES, VARIANTS THEREOF, AND USES THEREFORE

METHODS AND COMPOSITIONS FOR TREATING DISEASES AND CONDITIONS

PYRIMIDINES AND VARIANTS THEREOF, AND USES THEREFOR

CRYSTALLINE SALTS AND POLYMORPHS OF A P2X3 ANTAGONIST

METHODS AND COMPOSITIONS FOR TREATING DISEASES AND CONDITIONS

PYRIMIDINES AND VARIANTS THEREOF, AND USES THEREFOR